This article has been updated from a previous version to clarify the nature of the partnership between Evosep and Thermo Fisher.

NEW YORK (GenomeWeb) – Thermo Fisher Scientific and Evosep announced on Monday a partnership to develop and promote workflows for clinical proteomics.

The collaboration will be centered out of Thermo Fisher's Boston-based Precision Medicine Science Center and will combine its mass spec systems with Evosep's liquid chromatography to develop robust, high-throughput clinical proteomic methods, the companies said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

An opinion piece at Bloomberg discusses China's stance on genomic research.

Genetic ancestry testing can affect a person's sense of identity, the New York Times Magazine writes.

Nebula Genomics is launching its genome sequencing service for free for people who provide certain information about themselves, the Boston Globe reports.

In PLOS this week: grey wolf population genomics, mutations associated with lung adenocarcinoma survival, and more.